Skip to content
Search

Latest Stories

Pharmacists critical in helping people to practice self-care with confidence: survey

Pharmacists critical in helping people to practice self-care with confidence: survey

People are opting to visit pharmacists for self-care and are conscious of the positive impact it can have on alleviating healthcare system pressures, a new survey has found.

While it is still common for consumers across Europe to seek advice or reassurance from a GP, particularly when symptoms last longer than usual or are worse than normal, almost every second consumer (49%) has chosen to visit a pharmacist rather than a doctor for advice in the last year, even though a consultation was necessary from their point of view.


Around a fifth (19%) have done so multiple times, the survey of 5,000 European consumers, commissioned by consumer health company Kenvue, has found.

In the UK, findings show that pharmacists are a highly valued source of healthcare advice for consumers.

More than a quarter (29%) of those who had chosen to visit a pharmacist rather than a doctor in the last year said this was because they trust their local pharmacist to provide healthcare advice. Additionally, over one third said (35%) said this is where they typically turn to for healthcare advice, compared to 34 per cent who normally seek advice from their GP.

Kenvue said the high level of trust in pharmacists is positive news for healthcare systems more broadly.

Previous research showed that if self-medication were not available, around 120,000 more physicians would be required in Europe or, alternatively, each physician would have to work 2.4 hours longer per day [Association of the European Self-Care Industry, 2021].

This was echoed in the new survey, which found that if self-care treatments were less accessible, most UK consumers would visit a doctor for a prescription instead.

Survey responses indicate that consumers in the UK recognise the positive role that pharmacists and self-care play in building sustainable healthcare systems. Close to half (48%) who prefer to get treatments for minor ailments from a pharmacy said they do so to save doctors’ time.

Results also suggest that consumers would benefit from a greater understanding of the services and advice pharmacists offer, particularly when they feel unsure about what to do.

A quarter of the UK respondents currently choose to visit a doctor for minor ailments simply for reassurance (25%) and 15 per cent would see a doctor for guidance on product choice or dosage – both areas where pharmacists could provide advice and help consumers feel more confident about their self-care choices, the study noted.

“Empowering people to take control of their health is something we strive to do every day through our brands such as Nicorette, Zarbee’s, Benylin and Sudafed, because we know how impactful everyday care can be,” Angeliki Kazantzidi, Head of Marketing for Kenvue in Northern Europe, commented.

“It’s extremely positive to see that consumers in the UK recognise the importance of self-care and the role it can play in our healthcare system. Pharmacists have a crucial role to play as a source of expert healthcare advice and services, helping more consumers to practice self-care with confidence.”

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less